Back to News
Market Impact: 0.25

SK hynix is live on Nasdaq. One trading day until SKUU and SKDD.

BABA
SKHYV
SYBT
WWRL
Technology & InnovationArtificial IntelligenceCapital Returns (Dividends / Buybacks)Market Technicals & FlowsCompany Fundamentals

SK hynix began trading in US hours on Nasdaq under ticker SKHY after completing an approximately $29B ADR offering, the largest ever for an ADR. The launch also introduces GraniteShares’ 2x leveraged ETF (SKUU) and 2x inverse ETF (SKDD) targeting daily moves of SKHY, with institutional anchors reportedly committing about $7B pre-trade. The article frames upside around HBM demand for AI accelerators (forecast 2026 net profit growth above 400%) but flags sharp potential downside following SKHY’s ~710% rally and a recent ~25% drawdown as AI sentiment cooled.

Analysis

This is mainly a market-access and positioning event, not a new earnings event. US-hours trading should lower friction for global funds that were previously constrained by Korea-session liquidity, which can pull forward demand and raise the stock’s effective ownership ceiling; the flip side is that the same accessibility makes it easier for fast money to fade momentum, so the first week is more likely to feature wider ranges than a clean trend.

The second-order winner is the HBM ecosystem: if US investors decide SK hynix is the canonical AI memory bottleneck, that can mechanically lift implied cycle duration for MU and keep equipment/tooling names bid on the idea that memory capex stays elevated longer than consensus expects. The real loser is anyone short AI infrastructure; a durable re-rating in HBM would support the broader semis complex, but if the move stalls it will tell you the market is distinguishing between true earnings power and a one-off listing flow.

Contrarian read: the consensus is treating listing size as proof of structural quality, but the base case should be that this mostly changes who can own the stock, not what the stock is worth. After a huge prior run, the risk is multiple compression once novelty fades or if 2026 profit growth is revised down even modestly; what matters over the next 1-3 months is whether HBM pricing and customer allocation data confirm the scarcity story. Falsify the bull case if SKHYV cannot hold above its first-week volume-weighted average price, or if the ADR trades like a liquidity event rather than a persistent rerating.